- Location
drug candidates
"-
Living Tissues Could Be Built up Using a 3-D Printer Will Soon Revolutionize Many Fields
Feb 28, 2014Cross section of bioprinted human liver tissue showing hepatocytes (blue nuclei), endothelial cells (red), and hepatic stellate cells (green). (Courtesy Organovo Holdings Inc.) The discovery that living tissues could be built up using a ...
Tags: Organovo, 3-D printer
-
AMSBIO Has Launched CancerSeq
Feb 27, 2014AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
-
Biopta Introduces First Catalogue of Assays Based on Human Functional Tissues
Feb 27, 2014Biopta Ltd, the human tissue-based contract research organization, has announced the launch of the first catalogue of assays based on human functional tissues. The catalogue, which includes industry's widest range of human functional ...
-
Scientists From TSRI Developed a General Approach to Design Drugs From Genome Sequence
Feb 26, 2014In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
-
TM Platform Will Be Used to Screen for GPCR-Directed Allosteric Modulator Antibodies
Feb 14, 2014DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
-
Scientists at The University of California,San Diego Have Developed a New Genetic Platform
Jan 22, 2014Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound. Their study, published ...
-
Agios Pharmaceuticals Has Announced an Extension of One Additional Year
Dec 13, 2013US-based Agios Pharmaceuticals has announced an extension of one additional year to the period of exclusivity for their strategic cancer metabolism collaboration with Celgene. Celgene research president Dr Thomas Daniel noted the quality ...
-
Covagen Announced It Has Secured CHF42m in a Tranched Series B Financing
Dec 11, 2013Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
-
DRGT Has Entered Into a Multi-Year Collaboration Deal with Bayer Healthcare
Dec 10, 2013Druggability Technologies (DRGT) has entered into a multi-year collaboration deal with Bayer HealthCare that will deploy DRGT's proprietary Super-API platform to support Bayer HealthCare's formulation efforts directed at enhancing compound ...
Tags: Drugs Discovery, Bayer Healthcare
-
Biozone Pharmaceuticals Has Agreed to Terms and Signed a Letter of Intent to Merge
Nov 29, 2013US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
-
Viteava Pharmaceuticals Announced The Execution of an Exclusive Worldwide License
Nov 21, 2013Viteava Pharmaceuticals has announced the execution of an exclusive worldwide license to an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, ...
Tags: exclusive worldwide license, EGCG, Viteava Pharmaceuticals
-
Unilife Has Announced an Agreement with Medimmunefor Use in Medimmune's Pipeline
Nov 14, 2013Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
-
Advanced Proteome Therapeutics Has Announced The Achievement of an Important Milestone
Nov 12, 2013US-based Advanced Proteome Therapeutics has announced the achievement of an important milestone in its Cprogram with its collaborators by demonstrating that the first of a series of the company's site-specifically labeled protein conjugates ...
Tags: therapeutics, anti-cancer, proteome, Cprogram
-
Alzheon Announced The Launch of The Company,The Securing of Initial Private Financing
Oct 28, 2013Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
-
Zydus Cadila and Pieris Have Entered Into an Alliance
Oct 18, 2013Global pharmaceutical company Zydus Cadila and Pieris, a therapeutic protein research and development company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The ...